Vaccines against gonorrhea: current status and future challenges

Area of Science:

• Infectious Diseases and Vaccinology
• Microbiology and Immunology

Background:

• Gonorrhea presents a significant global health challenge with high incidence, impacting reproductive health and human immunodeficiency virus (HIV) spread.
• Current control strategies are compromised by the escalating emergence of antibiotic resistance in Neisseria gonorrhoeae.
• Limited progress in gonorrhea vaccine development necessitates renewed research efforts.

Purpose of the Study:

• To review recent advances in gonorrhea vaccine research, focusing on conserved antigens and immune response mechanisms.
• To highlight the potential of targeting key pathogenic roles of antigens with vaccine-induced responses.
• To emphasize the need for continued research, including human testing, to define protective host factors.

Main Methods:

• Identification of conserved vaccine antigens in Neisseria gonorrhoeae.
• Utilizing a murine genital tract infection model for systematic testing of antigens, immunization routes, and adjuvants.
• Elucidation of Neisseria gonorrhoeae's immune evasion mechanisms using human cells and the mouse model.
• Investigating the role of Th1 immune responses in clearing infection and inducing memory.

Main Results:

• Conserved antigens eliciting bactericidal antibodies and playing key roles in pathogenesis have been identified.
• A murine model allows for systematic evaluation of vaccine candidates and strategies.
• Induction of a Th1 response in mice demonstrated clearance of infection and established a memory response.

Conclusions:

• Recent scientific advances provide a strong foundation for gonorrhea vaccine development.
• Th1-inducing adjuvants may be critical for achieving vaccine-induced protection against gonorrhea.
• Further research, including clinical studies, is essential to validate experimental findings and identify protective host factors.